Terms: = Thyroid cancer AND CCDC6, D10S170, 8030, ENSG00000108091, Q16204, TPC, H4, TST1 AND Diagnosis
33 results:
1. [Stratified application of gene expression in diagnosis of thyroid nodules].
Guan WY; Zheng JY; Nie L; Wu HY
Zhonghua Bing Li Xue Za Zhi; 2024 Mar; 53(3):264-268. PubMed ID: 38433054
[No Abstract] [Full Text] [Related]
2. Clinical value of multi-gene testing in distinguishing benign and malignant thyroid nodules.
Zhang M; Hu X; Liu L; Wang Y; Jiang J; Li H; Fei W; Zhong T; Jiang Z
Medicine (Baltimore); 2024 Jan; 103(4):e35960. PubMed ID: 38277563
[TBL] [Abstract] [Full Text] [Related]
3. TIROSEC: Molecular, Clinical and Histopathological Profile of Papillary thyroid Carcinoma in a Colombian Cohort.
Cruz-Romero SD; González S; Juez JY; Becerra DS; Baldión AM; Hakim JA; González-Devia D; Perdomo S; Rodríguez-Urrego PA
Adv Ther; 2024 Feb; 41(2):792-805. PubMed ID: 38170436
[TBL] [Abstract] [Full Text] [Related]
4. Fasting regulates mitochondrial function through lncRNA PRKCQ-AS1-mediated IGF2BPs in papillary thyroid carcinoma.
Zhang X; Zhong Y; Liu L; Jia C; Cai H; Yang J; Wu B; Lv Z
Cell Death Dis; 2023 Dec; 14(12):827. PubMed ID: 38092752
[TBL] [Abstract] [Full Text] [Related]
5. Customized fluorescent probe for peering into the expression of butyrylcholinesterase in thyroid cancer.
Kang W; Ma M; Xu L; Tang S; Li J; Ma P; Song D; Sun Y
Anal Chim Acta; 2023 Nov; 1282():341932. PubMed ID: 37923409
[TBL] [Abstract] [Full Text] [Related]
6. Performance of multigene testing in cytologically indeterminate thyroid nodules and molecular risk stratification.
Zhou Y; Wu X; Zhang Y; Li Z; Ge X; Chen H; Mao Y; Ding W
PeerJ; 2023; 11():e16054. PubMed ID: 37744220
[TBL] [Abstract] [Full Text] [Related]
7. Highly sensitive droplet digital PCR for detection of RET fusion in papillary thyroid cancer.
Chen M; Xue J; Sang Y; Jiang W; He W; Hong S; Lv W; Xiao H; Liu R
BMC Cancer; 2023 Apr; 23(1):363. PubMed ID: 37081420
[TBL] [Abstract] [Full Text] [Related]
8. Three-dimensional genome landscape comprehensively reveals patterns of spatial gene regulation in papillary and anaplastic thyroid cancers: a study using representative cell lines for each cancer type.
Zhang L; Xu M; Zhang W; Zhu C; Cui Z; Fu H; Ma Y; Huang S; Cui J; Liang S; Huang L; Wang H
Cell Mol Biol Lett; 2023 Jan; 28(1):1. PubMed ID: 36609218
[TBL] [Abstract] [Full Text] [Related]
9. Sinomenine Hydrochloride Promotes TSHR-Dependent Redifferentiation in Papillary thyroid cancer.
Zhang J; Zhao A; Jia X; Li X; Liang Y; Liu Y; Xie X; Qu X; Wang Q; Zhang Y; Gao R; Yu Y; Yang A
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142613
[TBL] [Abstract] [Full Text] [Related]
10. Semaphorin 3D inhibits proliferation and migration of papillary thyroid carcinoma by regulating MAPK/ERK signaling pathway.
Hai R; You Q; Wu F; Qiu G; Yang Q; Shu L; Xie L; Zhou X
Mol Biol Rep; 2022 May; 49(5):3793-3802. PubMed ID: 35190928
[TBL] [Abstract] [Full Text] [Related]
11. Machine learning algorithms are comparable to conventional regression models in predicting distant metastasis of follicular thyroid carcinoma.
Mao Y; Lan H; Lin W; Liang J; Huang H; Li L; Wen J; Chen G
Clin Endocrinol (Oxf); 2023 Jan; 98(1):98-109. PubMed ID: 35171531
[TBL] [Abstract] [Full Text] [Related]
12. Diverse Oncogenic Fusions and Distinct Gene Expression Patterns Define the Genomic Landscape of Pediatric Papillary thyroid Carcinoma.
Stosic A; Fuligni F; Anderson ND; Davidson S; de Borja R; Acker M; Forte V; Campisi P; Propst EJ; Wolter NE; Chami R; Mete O; Malkin D; Shlien A; Wasserman JD
Cancer Res; 2021 Nov; 81(22):5625-5637. PubMed ID: 34535459
[TBL] [Abstract] [Full Text] [Related]
13. Anti-cancer impact of Hypericin in B-CPAP cells: Extrinsic caspase dependent apoptosis induction and metastasis obstruction.
Piryaei M; Mehrparvar B; Mohammadian A; Shahriari F; Javidi MA
Eur J Pharmacol; 2021 Nov; 910():174454. PubMed ID: 34454929
[TBL] [Abstract] [Full Text] [Related]
14. miR-1301-3p suppresses tumor growth by downregulating PCNA in thyroid papillary cancer.
Qiao DH; He XM; Yang H; Zhou Y; Deng X; Cheng L; Zhou XY
Am J Otolaryngol; 2021; 42(2):102920. PubMed ID: 33454555
[TBL] [Abstract] [Full Text] [Related]
15. IncRNA MAPKAPK5-AS1 promotes proliferation and migration of thyroid cancer cell lines by targeting miR-519e-5p/YWHAH.
Zhou Y; Liu S; Luo Y; Zhang M; Jiang X; Xiong Y
Eur J Histochem; 2020 Dec; 64(4):. PubMed ID: 33272009
[TBL] [Abstract] [Full Text] [Related]
16. miR-326 inhibits the progression of papillary thyroid carcinoma by targeting MAPK1 and ERBB4.
Nie FR; Li QX; Wei HF; Ma Y
Neoplasma; 2020 May; 67(3):604-613. PubMed ID: 32266816
[TBL] [Abstract] [Full Text] [Related]
17. Silencing of PPM1D inhibits cell proliferation and invasion through the p38 MAPK and p53 signaling pathway in papillary thyroid carcinoma.
Lu ZW; Wen D; Wei WJ; Han LT; Xiang J; Wang YL; Wang Y; Liao T; Ji QH
Oncol Rep; 2020 Mar; 43(3):783-794. PubMed ID: 31922231
[TBL] [Abstract] [Full Text] [Related]
18. miR24-2 Promotes Malignant Progression of Human Liver cancer Stem Cells by Enhancing Tyrosine Kinase Src Epigenetically.
Wang L; Li X; Zhang W; Yang Y; Meng Q; Wang C; Xin X; Jiang X; Song S; Lu Y; Pu H; Gui X; Li T; Xu J; Li J; Jia S; Lu D
Mol Ther; 2020 Feb; 28(2):572-586. PubMed ID: 31732298
[TBL] [Abstract] [Full Text] [Related]
19. Serous BMP8A has Clinical Significance in the Ultrasonic diagnosis of thyroid cancer and Promotes thyroid cancer Cell Progression.
Liu K; Gao M; Qin D; Wang H; Lu Q
Endocr Metab Immune Disord Drug Targets; 2020; 20(4):591-598. PubMed ID: 31656161
[TBL] [Abstract] [Full Text] [Related]
20. Long noncoding RNA ABHD11-AS1 functions as a competing endogenous RNA to regulate papillary thyroid cancer progression by miR-199a-5p/SLC1A5 axis.
Zhuang X; Tong H; Ding Y; Wu L; Cai J; Si Y; Zhang H; Shen M
Cell Death Dis; 2019 Aug; 10(8):620. PubMed ID: 31409775
[TBL] [Abstract] [Full Text] [Related]
[Next]